NewsAASLD Opens Call for Applications for Sites to Participate in TARGET-LD and the Cirrhosis Quality Collaborative (CQC Data Registry)Read more →Read more →
NewsWorld's Largest Liver Disease-Focused Registry Surpasses 400,000 Patient Enrollment MilestoneRead more →Read more →
NewsTarget RWE Launches Novel Precision Medicine Platform to Undertake Growing Unmet Medical Needs in Liver Disease, Gastroenterology, and Immune-mediated Inflammatory ConditionsRead more →Read more →
AASLD Opens Call for Applications for Sites to Participate in TARGET-LD and the Cirrhosis Quality Collaborative (CQC Data Registry)Read more →
World's Largest Liver Disease-Focused Registry Surpasses 400,000 Patient Enrollment MilestoneRead more →
Target RWE Launches Novel Precision Medicine Platform to Undertake Growing Unmet Medical Needs in Liver Disease, Gastroenterology, and Immune-mediated Inflammatory ConditionsRead more →
New Eosinophilic Gastrointestinal Disorders (EGIDs) Real World Registry Surpasses 1,000 Patient MilestoneRead more →
World-Leading Real World Data Registry, TARGET-NASH, Surpasses 7,000+ Enrolled Patients and 500,000+ Months of Patient Follow-UpRead more →
TARGET-DERM Real-World Study Success Leads To Global Site Expansion And New Dermatologic ConditionsRead more →
TARGET PharmaSolutions Launches TARGET-DERM Real-World Observational Study to Advance the Understanding of Atopic Dermatitis (Eczema) and Other Immune-Mediated Inflammatory Skin ConditionsRead more →
TARGET PharmaSolutions Initiates a New Community, TARGET-HBV, to Advance the Understanding of Hepatitis BRead more →
TARGET PharmaSolutions Enrolls First Participant in its Inflammatory Bowel Disease (IBD) CommunityRead more →
